Last 12 months
Inside the activity.
5 purchase rows · 5 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 1 | 1 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 4 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 3 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 1 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| October 01, 2026 Filed Oct 3, 2026 00:09 UTC |
Davis MyraDirector
|
GrantCommon Stock | 1,210 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-412265 · ownership.xml · nonDerivative · entry 1 Davis Myra · CIK 0002156047 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,210 F1 · balance_after: Includes 1,210 shares which were granted as restricted stock pursuant to the Company's Amended and Restated 2003 Stock Incentive Plan. Restrictions lapse as follows: 303 shares will vest on each of November 20, 2026, and March 6, 2027, and 605 shares will vest on May 20, 2027, subject to the Reporting Person's continued service as a director through each applicable vesting date. Read SEC document |
| September 14, 2026 Filed Sep 15, 2026 20:09 UTC |
Etta NchachaEVP & Chief Financial Officer
|
GrantCommon Stock | 6,831 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-391910 · ownership.xml · nonDerivative · entry 1 Etta Nchacha · CIK 0001976557 · EVP & Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,831 F1 · balance_after: Includes 6,831 shares which were granted as restricted stock pursuant to the Company's Amended and Restated 2003 Stock Incentive Plan. Restrictions lapse as follows: 427 shares will vest on each of November 20, 2026, March 6, 2027, May 20, 2027, August 20 2027, November 20, 2027, March 6, 2028, May 20, 2028, August 20 2028, November 20, 2028, March 6, 2029, May 20, 2029, August 20 2029, November 20, 2029, March 6, 2030, and May 20, 2030, and 426 shares will vest on August 20, 2030. Vesting is subject to his continued employment with the Company through each of the applicable vesting dates. Read SEC document |
| September 11, 2026 Filed Sep 14, 2026 20:17 UTC |
Minan Peter FrancisDirector
|
PurchaseCommon Stock | 5.27 | $79.00 | $416.33 |
DisclosureSEC source: 0001193125-26-390608 · ownership.xml · nonDerivative · entry 2 Minan Peter Francis · CIK 0001544647 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,217.14 F3 · shares: Represents shares acquired through automatic reinvestment of cash dividends in the Reporting Person's brokerage account. F2 · balance_after: Includes 1,153 shares which were granted as restricted stock pursuant to the Company Amended and Restated 2003 Stock Incentive Plan. Restrictions lapse as follows: 576 shares on November 20, 2026 and 577 shares on March 6, 2027, if he is a director of the Company on those dates. Read SEC document |
| August 20, 2026 Filed Aug 24, 2026 23:12 UTC |
Williams Eric JosephPresident and COO
|
Tax withholdingCommon Stock | 714 | $78.00 | $55,692.00 |
DisclosureSEC source: 0001193125-26-363896 · ownership.xml · nonDerivative · entry 1 Williams Eric Joseph · CIK 0001871391 · President and COO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 39,617 F1 · shares: The reporting person surrendered shares to the issuer to satisfy applicable tax withholding obligations upon vesting. F2 · balance_after: Includes 24,402 shares which were granted as restricted stock pursuant to the Company's Amended and Restated 2003 Stock Incentive Plan. Restrictions lapse as follows: 2,512 shares will vest on November 20, 2026, 2,520 shares vest on March 6, 2027, 2,200 shares vest on each of May 20, 2027, August 20, 2027, and November 20, 2027, 2,204 shares vest on March 6, 2028, 1,694 shares vest on each of May 20, 2028, August 20, 2028, and November 20, 2028, 1,716 shares will vest on March 6, 2029, 936 shares vest on each of May 20, 2029, August 20, 2029 and November 20, 2029, and 960 shares will vest on March 6, 2030. Vesting is subject to his continued employment with the Company through each of the applicable vesting dates. Read SEC document |
| August 20, 2026 Filed Aug 24, 2026 23:09 UTC |
CURTIS JASON TRAVISInterim CFO
|
Tax withholdingCommon Stock | 40 | $78.00 | $3,120.00 |
DisclosureSEC source: 0001193125-26-363894 · ownership.xml · nonDerivative · entry 1 CURTIS JASON TRAVIS · CIK 0001750716 · Interim CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,853 F1 · shares: The reporting person surrendered shares to the issuer to satisfy applicable tax withholding obligations upon vesting. F2 · balance_after: Includes 3,425 shares of common stock subject to vesting restrictions. The shares were granted as restricted stock pursuant to the Company's Amended and Restated 2003 Stock Incentive Plan. Restrictions lapse as follows: 171 shares vest on each of November 20, 2026, and March 6, 2027, 1,250 shares vest on May 15, 2027, 171 shares vest on each of May 20, 2027, August 20, 2027, November 20, 2027, March 6, 2028, May 20, 2028, August 20, 2028, November 20, 2028, and March 6, 2029, 178 shares vest on May 20, 2029, 93 shares vest on each of August 20, 2029 and November 20, 2029, and 101 shares vest on March 6, 2030. Vesting is contingent upon the reporting person's continued service with the Company through each applicable vesting date. Read SEC document |
| August 20, 2026 Filed Aug 24, 2026 23:07 UTC |
Binstein RichardEVP Gen'l Counsel & Secretary
|
Tax withholdingCommon Stock | 450 | $78.00 | $35,100.00 |
DisclosureSEC source: 0001193125-26-363890 · ownership.xml · nonDerivative · entry 1 Binstein Richard · CIK 0001919840 · EVP Gen'l Counsel & Secretary 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 24,417 F1 · shares: The reporting person surrendered shares to the issuer to satisfy applicable tax withholding obligations upon vesting. F2 · balance_after: Includes 17,330 shares which were granted as restricted stock pursuant to the Company's Amended and Restated 2003 Stock Incentive Plan. Restrictions lapse as follows: 1,870 shares will vest on November 20, 2026, 1,876 shares will vest on March 6, 2027, 1,636 shares will vest on each of May 20, 2027, August 20, 2027, and November 20, 2027, 1,640 shares will vest on March 6, 2028, 1,130 shares will vest on each of May 20, 2028, August 20, 2028, and November 20, 2028, 1,134 shares will vest on March 6, 2029, 624 shares will vest on each of May 20, 2029, August 20, 2029, and November 20, 2029 and 640 shares will vest on March 6, 2030, if he is an employee of the Company on those dates. Read SEC document |
| August 20, 2026 Filed Aug 24, 2026 23:04 UTC | Tax withholdingCommon Stock | 762 | $78.00 | $59,436.00 |
DisclosureSEC source: 0001193125-26-363888 · ownership.xml · nonDerivative · entry 1 REEVE GRAHAM D. · CIK 0001519948 · COO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 28,554 F1 · shares: The reporting person surrendered shares to the issuer to satisfy applicable tax withholding obligations upon vesting. F2 · balance_after: Includes 17,488 shares which were granted as restricted stock pursuant to the Company's Amended and Restated 2003 Stock Incentive Plan. Restrictions lapse as follows: 1,948 shares will vest on November 20, 2026, 1,956 shares will vest on March 6, 2027, 1,636 shares will vest on each of May 20, 2027, August 20, 2027, and November 20, 2027, 1,640 shares will vest on March 6, 2028, 1,130 shares will vest on each of May 20, 2028, August 20, 2028, and November 20, 2028, 1,134 shares will vest on March 6, 2029, 624 shares will vest on each of May 20, 2029, August 20, 2029, and November 20, 2029 and 640 shares will vest on March 6, 2030, if he is an employee of the Company on those dates. Read SEC document |
|
| June 12, 2026 Filed Sep 14, 2026 20:17 UTC |
Minan Peter FrancisDirector
|
PurchaseCommon Stock | 0.87 | $66.50 | $57.86 |
DisclosureSEC source: 0001193125-26-390608 · ownership.xml · nonDerivative · entry 1 Minan Peter Francis · CIK 0001544647 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,211.87 F1 · shares: Represents a fractional share acquired through the automatic reinvestment of cash dividends in the Reporting Person's brokerage account. This transaction was inadvertently not reported previously and is being reported on this Form 4. F2 · balance_after: Includes 1,153 shares which were granted as restricted stock pursuant to the Company Amended and Restated 2003 Stock Incentive Plan. Restrictions lapse as follows: 576 shares on November 20, 2026 and 577 shares on March 6, 2027, if he is a director of the Company on those dates. Read SEC document |
| June 09, 2026 Filed Jun 10, 2026 22:36 UTC |
Minan Peter FrancisDirector
|
PurchaseCommon Stock | 288 | $61.50 | $17,712.00 |
DisclosureSEC source: 0001193125-26-266197 · ownership.xml · nonDerivative · entry 2 Minan Peter Francis · CIK 0001544647 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,211 F1 · balance_after: Includes 2,306 shares which were granted as restricted stock pursuant to the Company Amended and Restated 2003 Stock Incentive Plan. Restrictions lapse as to 1,153 shares on August 20, 2026, 576 shares on November 20, 2026 and 577 shares on March 6, 2027, if he is a director of the Company on those dates. Read SEC document |
| June 08, 2026 Filed Jun 10, 2026 22:36 UTC |
Minan Peter FrancisDirector
|
PurchaseCommon Stock | 492 | $63.14 | $31,064.88 |
DisclosureSEC source: 0001193125-26-266197 · ownership.xml · nonDerivative · entry 1 Minan Peter Francis · CIK 0001544647 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,923 F1 · balance_after: Includes 2,306 shares which were granted as restricted stock pursuant to the Company Amended and Restated 2003 Stock Incentive Plan. Restrictions lapse as to 1,153 shares on August 20, 2026, 576 shares on November 20, 2026 and 577 shares on March 6, 2027, if he is a director of the Company on those dates. Read SEC document |
| May 20, 2026 Filed Jun 22, 2026 21:01 UTC |
CURTIS JASON TRAVISInterim CFO
|
Tax withholdingCommon Stock | 40 | $62.24 | $2,489.60 |
DisclosureSEC source: 0001193125-26-277664 · ownership.xml · nonDerivative · entry 1 CURTIS JASON TRAVIS · CIK 0001750716 · Interim CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,893 F1 · shares: The reporting person surrendered shares to the issuer to satisfy applicable tax withholding obligations upon vesting. F2 · balance_after: Includes 3,596 shares of common stock subject to vesting restrictions. The shares were granted as restricted stock pursuant to the Company's Amended and Restated 2003 Stock Incentive Plan. Restriction lapse as follows: 171 shares vest on each of August 20, 2026, November 20, 2026, and March 6, 2027; 1,250 shares vest on May 15, 2027; 171 shares vest on each of May 20, 2027, August 20, 2027, November 20, 2027, March 6, 2028, May 20, 2028, August 20, 2028, November 20, 2028, and March 6, 2029; 178 shares vest on May 20, 2029; 93 shares vest on each of August 20, 2029 and November 20, 2029; and 101 shares vest on March 6, 2030. Vesting is contingent upon the reporting person's continued service with the Company through each applicable vesting date. Read SEC document |
| May 20, 2026 Filed Jun 22, 2026 20:57 UTC | Tax withholdingCommon Stock | 762 | $62.24 | $47,426.88 |
DisclosureSEC source: 0001193125-26-277646 · ownership.xml · nonDerivative · entry 1 REEVE GRAHAM D. · CIK 0001519948 · COO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 29,316 F1 · shares: The reporting person surrendered shares to the issuer to satisfy applicable tax withholding obligations upon vesting. F2 · balance_after: Includes 19,436 shares which were granted as restricted stock pursuant to the Company's Amended and Restated 2003 Stock Incentive Plan. Restriction lapse as follows: 1,948 shares will vest on each of August 20, 2026 and November 20, 2026, 1,956 shares will vest on March 6, 2027, 1,636 shares will vest on each of May 20, 2027, August 20, 2027, and November 20, 2027, 1,640 shares will vest on March 6, 2028, 1,130 shares will vest on each of May 20, 2028, August 20, 2028, and November 20, 2028, 1,134 shares will vest on March 6, 2029, 624 shares will vest on each of May 20, 2029, August 20, 2029, and November 20, 2029 and 640 shares will vest on March 6, 2030, if he is an employee of the Company on those dates. Read SEC document |
|
| May 19, 2026 Filed May 20, 2026 20:39 UTC |
Motsenbocker AnneDirector
|
GrantCommon Stock | 2,306 | $61.61 | $142,072.66 |
DisclosureSEC source: 0001193125-26-232731 · ownership.xml · nonDerivative · entry 1 Motsenbocker Anne · CIK 0001904253 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,812 F1 · balance_after: Includes 2,306 shares which were granted as restricted stock pursuant to the Company Amended and Restated 2003 Stock Incentive Plan. Restrictions lapse as to 1,153 shares on August 20, 2026, 576 shares on November 20, 2026 and 577 shares on March 6, 2027, if she is a director of the Company on those dates. Read SEC document |
| May 19, 2026 Filed May 20, 2026 20:20 UTC |
Swanson Regg E.Director
|
GrantCommon Stock | 2,306 | $61.61 | $142,072.66 |
DisclosureSEC source: 0001193125-26-232641 · ownership.xml · nonDerivative · entry 1 Swanson Regg E. · CIK 0001412473 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,492 F1 · balance_after: Includes 2,306 shares which were granted as restricted stock pursuant to the Company Amended and Restated 2003 Stock Incentive Plan. Restrictions lapse as to 1,153 shares on August 20, 2026, 576 shares on November 20, 2026 and 577 shares on March 6, 2027, if he is a director of the Company on those dates. Read SEC document |
| May 19, 2026 Filed May 20, 2026 20:14 UTC |
Minan Peter FrancisDirector
|
GrantCommon Stock | 2,306 | $61.61 | $142,072.66 |
DisclosureSEC source: 0001193125-26-232596 · ownership.xml · nonDerivative · entry 1 Minan Peter Francis · CIK 0001544647 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,431 F1 · balance_after: Includes 2,306 shares which were granted as restricted stock pursuant to the Company Amended and Restated 2003 Stock Incentive Plan. Restrictions lapse as to 1,153 shares on August 20, 2026, 576 shares on November 20, 2026 and 577 shares on March 6, 2027, if he is a director of the Company on those dates. Read SEC document |
| May 19, 2026 Filed May 20, 2026 20:12 UTC |
Harris Bernard A JrDirector
|
GrantCommon Stock | 2,306 | $61.61 | $142,072.66 |
DisclosureSEC source: 0001193125-26-232590 · ownership.xml · nonDerivative · entry 1 Harris Bernard A Jr · CIK 0001337906 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,914 F1 · balance_after: Includes 2,306 shares which were granted as restricted stock pursuant to the Company Amended and Restated 2003 Stock Incentive Plan. Restrictions lapse as to 1,153 shares on August 20, 2026, 576 shares on November 20, 2026 and 577 shares on March 6, 2027, if he is a director of the Company on those dates. Read SEC document |
| May 19, 2026 Filed May 20, 2026 20:08 UTC |
Gilmartin Kathleen ADirector
|
GrantCommon Stock | 2,306 | $61.61 | $142,072.66 |
DisclosureSEC source: 0001193125-26-232573 · ownership.xml · nonDerivative · entry 1 Gilmartin Kathleen A · CIK 0001741732 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 27,092 F1 · balance_after: Includes 2,306 shares which were granted as restricted stock pursuant to the Company Amended and Restated 2003 Stock Incentive Plan. Restrictions lapse as to 1,153 shares on August 20, 2026, 576 shares on November 20, 2026 and 577 shares on March 6, 2027, if she is a director of the Company on those dates. Read SEC document |
| May 19, 2026 Filed May 28, 2026 20:22 UTC Amendment |
Swanson Regg E.Director
|
GrantCommon Stock | 2,306 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-245298 · ownership.xml · nonDerivative · entry 1 Swanson Regg E. · CIK 0001412473 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,492 F1 · price: 5/19/2026 - Transaction price should have been reported as $0.00, not $61.61. F2 · balance_after: Includes 2,306 shares which were granted as restricted stock pursuant to the Company Amended and Restated 2003 Stock Incentive Plan. Restrictions lapse as to 1,153 shares on August 20, 2026, 576 shares on November 20, 2026 and 577 shares on March 6, 2027, if he is a director of the Company on those dates. Read SEC document |
| May 19, 2026 Filed May 28, 2026 20:19 UTC Amendment |
Motsenbocker AnneDirector
|
GrantCommon Stock | 2,306 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-245285 · ownership.xml · nonDerivative · entry 1 Motsenbocker Anne · CIK 0001904253 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,812 F1 · price: 5/19/2026 - Transaction price should have been reported as $0.00, not $61.61. F2 · balance_after: Includes 2,306 shares which were granted as restricted stock pursuant to the Company Amended and Restated 2003 Stock Incentive Plan. Restrictions lapse as to 1,153 shares on August 20, 2026, 576 shares on November 20, 2026 and 577 shares on March 6, 2027, if she is a director of the Company on those dates. Read SEC document |
| May 19, 2026 Filed May 28, 2026 20:14 UTC Amendment |
Minan Peter FrancisDirector
|
GrantCommon Stock | 2,306 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-245256 · ownership.xml · nonDerivative · entry 1 Minan Peter Francis · CIK 0001544647 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,431 F1 · price: 5/19/2026 - Transaction price should have been reported as $0.00, not $61.61. F2 · balance_after: Includes 2,306 shares which were granted as restricted stock pursuant to the Company Amended and Restated 2003 Stock Incentive Plan. Restrictions lapse as to 1,153 shares on August 20, 2026, 576 shares on November 20, 2026 and 577 shares on March 6, 2027, if he is a director of the Company on those dates. Read SEC document |
| May 19, 2026 Filed May 28, 2026 20:11 UTC Amendment |
Harris Bernard A JrDirector
|
GrantCommon Stock | 2,306 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-245238 · ownership.xml · nonDerivative · entry 1 Harris Bernard A Jr · CIK 0001337906 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,914 F1 · price: 5/19/2026 - Transaction price should have been reported as $0.00, not $61.61. F2 · balance_after: Includes 2,306 shares which were granted as restricted stock pursuant to the Company Amended and Restated 2003 Stock Incentive Plan. Restrictions lapse as to 1,153 shares on August 20, 2026, 576 shares on November 20, 2026 and 577 shares on March 6, 2027, if he is a director of the Company on those dates. Read SEC document |
| May 19, 2026 Filed May 28, 2026 20:08 UTC Amendment |
Gilmartin Kathleen ADirector
|
GrantCommon Stock | 2,306 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-245224 · ownership.xml · nonDerivative · entry 1 Gilmartin Kathleen A · CIK 0001741732 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 27,092 F1 · price: 5/19/2026 - Transaction price should have been reported as $0.00, not $61.61. F2 · balance_after: Includes 2,306 shares which were granted as restricted stock pursuant to the Company Amended and Restated 2003 Stock Incentive Plan. Restrictions lapse as to 1,153 shares on August 20, 2026, 576 shares on November 20, 2026 and 577 shares on March 6, 2027, if she is a director of the Company on those dates. Read SEC document |
| March 11, 2026 Filed Mar 12, 2026 20:41 UTC | SaleCommon Stock | 662 | $78.86 | $52,205.32 |
DisclosureSEC source: 0001193125-26-104315 · ownership.xml · nonDerivative · entry 1 REEVE GRAHAM D. · CIK 0001519948 · COO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 30,078 F1 · price: The price reported ($78.86) is the weighted average price. The shares were sold in multiple transactions at prices ranging from $78.82 to $79.82 per share, both inclusive. The reporting person undertakes to provide to U.S. Physical Therapy, Inc., any of its shareholders or the staff of the Securities & Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4. F2 · balance_after: Includes 21,384 shares which were granted as restricted stock pursuant to the Company's Amended and Restated 2003 Stock Incentive Plan. Restriction lapse as follows: 1,948 shares will vest on each of May 20, 2026, August 20, 2026 and November 20, 2026, 1,956 shares will vest on March 6, 2027, 1,636 shares will vest on each of May 20, 2027, August 20, 2027, and November 20, 2027, 1,640 shares will vest on March 6, 2028, 1,130 shares will vest on each of May 20, 2028, August 20, 2028, and November 20, 2028, 1,134 shares will vest on March 6, 2029, 624 shares will vest on each of May 20, 2029, August 20, 2029, and November 20, 2029 and 640 shares will vest on March 6, 2030, if he is an employee of the Company on those dates. Read SEC document |
|
| March 09, 2026 Filed Mar 10, 2026 21:21 UTC |
HENDRICKSON CAREY PChief Financial Officer
|
Disposition to issuerCommon Stock | 10,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-100453 · ownership.xml · nonDerivative · entry 1 HENDRICKSON CAREY P · CIK 0001482760 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 27,808 F1 · balance_after: Includes 11,070 shares which were granted as restricted stock pursuant to the Company's Amended and Restated 2003 Stock Incentive Plan. Restriction lapse as follows: 1,246 shares will vest on each of May 20, 2026, August 20, 2026 and November 20, 2026, 1,252 shares will vest on March 6, 2027, 1,012 shares will vest on each of May 20, 2027, August 20, 2027, and November 20, 2027, 1,016 shares will vest on March 6, 2028, 506 shares will vest on each of May 20, 2028, August 20, 2028, and November 20, 2028, 510 shares will vest on March 6, 2029 if he remains employed by the Company on those dates. Read SEC document |
| March 09, 2026 Filed Mar 11, 2026 20:38 UTC | SaleCommon Stock | 1 | $78.52 | $78.52 |
DisclosureSEC source: 0001193125-26-102296 · ownership.xml · nonDerivative · entry 2 REEVE GRAHAM D. · CIK 0001519948 · COO 10b5-1 filing: No plan indicated Ownership: Indirect · Reeve Trust Disclosed balance after: 0 Read SEC document |
|
| March 06, 2026 Filed Mar 9, 2026 20:28 UTC |
Binstein RichardEVP Gen'l Counsel & Secretary
|
SaleCommon Stock | 3,000 | $81.64 | $244,920.00 |
DisclosureSEC source: 0001193125-26-098618 · ownership.xml · nonDerivative · entry 1 Binstein Richard · CIK 0001919840 · EVP Gen'l Counsel & Secretary 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 24,867 F1 · balance_after: Includes 21,070 shares which were granted as restricted stock pursuant to the Company's Amended and Restated 2003 Stock Incentive Plan. Restriction lapse as to 1,870 shares will vest on each of May 20, 2026, August 20, 2026 and November 20, 2026, 1,876 shares will vest on March 6, 2027, 1,636 shares will vest on each of May 20, 2027, August 20, 2027, and November 20, 2027, 1,640 shares will vest on March 6, 2028, 1,130 shares will vest on each of May 20, 2028, August 20, 2028, and November 20, 2028, 1,134 shares will vest on March 6, 2029, 624 shares will vest on each of May 20, 2029, August 20, 2029, and November 20, 2029 and 640 shares will vest on March 6, 2030, if he is an employee of the Company on those dates. Read SEC document |
| March 06, 2026 Filed Mar 11, 2026 20:38 UTC | SaleCommon Stock | 1,807 | $82.25 | $148,625.75 |
DisclosureSEC source: 0001193125-26-102296 · ownership.xml · nonDerivative · entry 1 REEVE GRAHAM D. · CIK 0001519948 · COO 10b5-1 filing: No plan indicated Ownership: Indirect · Reeve Trust Disclosed balance after: 1 Read SEC document |
|
| February 23, 2026 Filed Feb 26, 2026 01:46 UTC |
READING CHRISTOPHER JDirector · Chairman of the Board and CEO
|
GrantCommon Stock | 25,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-072717 · ownership.xml · nonDerivative · entry 1 READING CHRISTOPHER J · CIK 0001270356 · Director · Chairman of the Board and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 139,088 F1 · shares: These shares of common stock were granted as restricted stock pursuant to the Company's Amended and Restated 2003 Stock Incentive Plan. The restrictions lapse in 15 equal quarterly installments of 1,562 shares beginning on May 20, 2026 and on each of March 6, May 20, August 20, and November 20 of each of the years 2026, 2027, 2028, and 2029 and 1,570 shares vesting on March 6, 2030 F2 · balance_after: Includes 54,946 shares, inclusive of those mentioned in Footnote 1, which were granted as restricted stock pursuant to the Company's Amended and Restated 2003 Stock Incentive Plan. Restriction lapse as follows: 4,152 shares vest on March 6, 2026; 4,464 shares vest on each of May 20, 2026, August 20, 2026, November 20, 2026 and March 6, 2027; 3,839 shares vest on each of May 20, 2027, August 20, 2027, and November 20, 2027; 3,847 shares vest on March 6, 2028; 2,827 shares vest on each of May 20, 2028, August 20, 2028, and November 20, 2028; 2,837 shares vest on March 6, 2029; 1,562 shares vest on each of May 20, 2029, August 20, 2029, and November 20, 2029 and 1,570 shares vest on March 6, 2030. Vesting is subject to his continued employment with the Company through each applicable vesting date. Read SEC document |
| February 23, 2026 Filed Feb 26, 2026 01:42 UTC | GrantCommon Stock | 10,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-072703 · ownership.xml · nonDerivative · entry 1 REEVE GRAHAM D. · CIK 0001519948 · COO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 30,740 F1 · shares: These shares of common stock were granted as restricted stock pursuant to the Company's Amended and Restated 2003 Stock Incentive Plan. Restrictions lapse in 15 quarterly installments of 624 shares vesting beginning on May 20, 2026 and on each of March 6, May 20, August 20, and November 20 of each year 2026, 2027, 2028, and 2029 and 640 shares vesting on March 6, 2030, if he still employed by the Company as of those dates. F2 · balance_after: Includes 23,348 shares, inclusive of those mentioned in Footnote 1, which were granted as restricted stock pursuant to the Company's Amended and Restated 2003 Stock Incentive Plan. Restriction lapse as follows: 1,964 shares will vest on March 6, 2026; 1,948 shares will vest on each of May 20, 2026, August 20, 2026, November 20, 2026; 1,956 shares will vest on March 6, 2027; 1,636 shares will vest on each of May 20, 2027, August 20, 2027, and November 20, 2027; 1,640 shares will vest on March 6, 2028; 1,130 shares will vest on each of May 20, 2028, August 20, 2028, November 20, 2028; 1,134 shares will vest on March 6, 2029; 624 shares will vest on each of May 20, 2029, August 20, 2029, November 20, 2029 and the remaining 640 shares will vest on March 6, 2030. Vesting is subject to his continued employment with the Company through each applicable vesting date. Read SEC document |
|
| February 23, 2026 Filed Feb 26, 2026 01:21 UTC |
Binstein RichardEVP Gen'l Counsel & Secretary
|
GrantCommon Stock | 10,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-072647 · ownership.xml · nonDerivative · entry 1 Binstein Richard · CIK 0001919840 · EVP Gen'l Counsel & Secretary 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 27,867 F1 · shares: These shares of common stock were granted as restricted stock pursuant to the Company's Amended and Restated 2003 Stock Incentive Plan. Restrictions lapse in 15 quarterly installments of 624 shares vesting beginning on May 20, 2026 and on each of March 6, May 20, August 20, and November 20 of each year 2026, 2027, 2028 and 2029 and 640 shares vesting on March 6, 2030, if he still employed by the Company as of those dates. F2 · balance_after: Includes 22,624 (including the awards mentioned in note 1) which were granted as restricted stock pursuant to the Company's Amended and Restated 2003 Stock Incentive Plan. Restriction lapse as to 1,554 shares will vest on March 6, 2026, 1,870 shares will vest on each of May 20, 2026, August 20, 2026 and November 20, 2026, 1,876 shares on March 6, 2027, 1,636 shares will vest on each of May 20, 2027, August 20, 2027 and November 20, 2027, 1,640 shares will vest on March 6, 2028, 1,130 shares will vest on each of May 20, 2028, August 20, 2028 and November 20, 2028, 1,134 shares will vest on March 6, 2029, 624 shares will vest on each of May 20, 2029, August 20, 2028 and November 20, 2029 and the final 640 shares will vest on March 6, 2030. Read SEC document |
| February 23, 2026 Filed Feb 26, 2026 01:45 UTC |
Williams Eric JosephPresident and COO
|
GrantCommon Stock | 15,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-072715 · ownership.xml · nonDerivative · entry 1 Williams Eric Joseph · CIK 0001871391 · President and COO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 40,331 F1 · shares: These shares of common stock were granted as restricted stock pursuant to the Company's Amended and Restated 2003 Stock Incentive Plan. The restrictions lapse in fifteen (15) equal quarterly installments of 936 shares vesting on each of May 20, August 20, November 20, and March 6 of each of the years 2026, 2027, 2028, and 2029. The final 960 shares vesting on March 6, 2030. Vesting is subject to his continued employment with the Company through each of the applicable vesting dates. F2 · balance_after: Includes 31,322 shares, inclusive of those mentioned in Footnote 1, which were granted as restricted stock pursuant to the Company's Amended and Restated 2003 Stock Incentive Plan. Restriction lapse as follows: 1,896 shares vest on March 6, 2026; 2,512 shares vest on May 20, 2026, August 20, 2026, November 20, 2026; 2,520 shares vest on March 6, 2027; 2,200 shares vest on May 20, 2027, August 20, 2027, and November 20, 2027; 2,204 shares vest on March 6, 2028; 1,694 shares vest on May 20, 2028, August 20, 2028, and November 20, 2028; 1,716 shares will vest on March 6, 2029; 936 shares vest on May 20, 2029, August 20, 2029 and November 20, 2029; and 960 shares will vest on March 6, 2030. Vesting is subject to his continued employment with the Company through each of the applicable vesting dates. Read SEC document |
| February 23, 2026 Filed Feb 26, 2026 01:15 UTC |
HENDRICKSON CAREY PChief Financial Officer
|
GrantCommon Stock | 10,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-072630 · ownership.xml · nonDerivative · entry 1 HENDRICKSON CAREY P · CIK 0001482760 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 37,808 F1 · shares: These shares of common stock were granted as restricted stock pursuant to the Company's Amended and Restated 2003 Stock Incentive Plan. The restrictions lapse in fifteen (15) equal quarterly installments of 624 shares each, vesting on May 20, August 20, and November 20 of 2026, and March 6, May 20, August 20, and November 20 in each of the years 2027, 2028, and 2029; and 640 shares which will vest on March 6, 2030. F2 · balance_after: Includes 22,796 shares, inclusive of those mentioned in Footnote 1, which were granted as restricted stock pursuant to the Company's Amended and Restated 2003 Stock Incentive Plan. Restriction lapse as follows: 1,726 shares will vest on March 6, 2026; 1,870 shares will vest on each of May 20, 2026, August 20, 2026, November 20, 2026; 1,876 shares will vest on March 6, 2027; 1,636 shares will vest on each of May 20, 2027, August 20, 2027, and November 20, 2027; 1,640 shares will vest on March 6, 2028; 1,130 shares will vest on each of May 20, 2028, August 20, 2028, November 20, 2028; 1,134 shares will vest on March 6, 2029; 624 shares will vest on each of May 20, 2029, August 20, 2029, November 20, 2029 and the remaining 640 shares will vest on March 6, 2030. Vesting is subject to his continued employment with the Company through each applicable vesting date. Read SEC document |
| November 24, 2025 Filed Nov 25, 2025 21:08 UTC | SaleCommon Stock | 743 | $71.01 | $52,760.43 |
DisclosureSEC source: 0001193125-25-297192 · ownership.xml · nonDerivative · entry 1 REEVE GRAHAM D. · CIK 0001519948 · COO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,740 F1 · price: The price reported $71.01 is the weighted average price. The shares were sold in multiple transactions at prices ranging from $71.01 to $71.31 per share, both inclusive. The reporting person undertakes to provide to U.S. Physical Therapy, Inc., any of its shareholders or the staff of the Securities & Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4. F2 · balance_after: Includes 13,348 shares which were granted as restricted stock pursuant to the Company's Amended and Restated 2003 Stock Incentive Plan. Restrictions lapse as to 1,964 shares on March 6, 2026, 1,324 shares on each of May 20, 2026, August 20, 2026, and November 20, 2026, 1,332 shares on March 6, 2027, 1,012 shares on each of May 20, 2027, August 20, 2027, and November 20, 2027, 1,016 shares on March 6, 2028, 506 shares of each on May 20, 2028, August 20, 2028, and November 20, 2028, and 510 shares on March 6, 2029, if he is an employee of the Company on those dates. Read SEC document |
|
| November 20, 2025 Filed Nov 24, 2025 21:09 UTC |
Gilmartin Kathleen ADirector
|
PurchaseCommon Stock | 4,000 | $69.00 | $276,000.00 |
DisclosureSEC source: 0001193125-25-293697 · ownership.xml · nonDerivative · entry 1 Gilmartin Kathleen A · CIK 0001741732 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 24,786 F1 · balance_after: Includes 471 shares which were granted as restricted stock pursuant to the Company's Amended and Restated 2003 Stock Incentive Plan. These shares will fully vest on March 6, 2026 if she remains as a member of the Board of Directors of the Company on that date. Read SEC document |
| September 11, 2025 Filed Sep 11, 2025 20:51 UTC |
HAM NANCYDirector
|
SaleCommon Stock | 600 | $81.71 | $49,026.00 |
DisclosureSEC source: 0000950170-25-114258 · ownership.xml · nonDerivative · entry 1 HAM NANCY · CIK 0001124500 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,994 F1 · balance_after: Includes 941 shares which were granted as restricted stock pursuant to the Company Amended and Restated 2003 Stock Incentive Plan. Restrictions lapse as to 470 shares on November 20, 2025, and 471 shares on March 6, 2026, if she is a director of the Company on those dates. Read SEC document |
| September 05, 2025 Filed Sep 8, 2025 20:15 UTC |
Williams Eric JosephPresident and COO
|
SaleCommon Stock | 1,000 | $85.25 | $85,250.00 |
DisclosureSEC source: 0000950170-25-113554 · ownership.xml · nonDerivative · entry 1 Williams Eric Joseph · CIK 0001871391 · President and COO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25,331 F1 · balance_after: Includes 18,210 shares which were granted as restricted stock pursuant to the Company's Amended and Restated 2003 Stock Incentive Plan. Restrictions lapse as to 1,888 shares on November 20, 2025, 1,896 shares on March 6, 2026,1,576 shares on each of May 20, 2026, August 20, 2026, and November 20, 2026, 1,584 shares on March 6, 2027, 1,264 shares on each of May 20, 2027, August 20, 2027, and November 20, 2027, 1,268 shares on March 6, 2028, 758 shares on each of May 20, 2028, August 20, 2028, November 20, 2028, and 780 shares on March 6, 2029, if he is an employee of the Company on those dates. Read SEC document |
| September 04, 2025 Filed Sep 5, 2025 20:15 UTC |
READING CHRISTOPHER JDirector · Chairman of the Board and CEO
|
SaleCommon Stock | 2,000 | $83.53 | $167,060.00 |
DisclosureSEC source: 0000950170-25-113254 · ownership.xml · nonDerivative · entry 1 READING CHRISTOPHER J · CIK 0001270356 · Director · Chairman of the Board and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 114,088 F1 · balance_after: Includes 34,098 shares which were granted as restricted stock pursuant to the Company's Amended and Restated 2003 Stock Incentive Plan. Restrictions lapse as to 4,152 shares on each of November 20, 2025 and March 6, 2026, 2,902 shares on each of May 20, 2026, August 20, 2026, November 20, 2026, and March 6, 2027, 2,277 shares on each of May 20, 2027, August 20, 2027, and November 20, 2027, 2,285 shares on March 6, 2028,1,265 shares on each of May 20, 2028, August 20, 2028, and November 20, 2028, and 1,275 shares on March 6, 2029, if he is an employee of the Company on those dates. Read SEC document |
| August 25, 2025 Filed Aug 25, 2025 21:30 UTC |
HENDRICKSON CAREY PChief Financial Officer
|
SaleCommon Stock | 698 | $86.11 | $60,104.78 |
DisclosureSEC source: 0000950170-25-111251 · ownership.xml · nonDerivative · entry 1 HENDRICKSON CAREY P · CIK 0001482760 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 27,808 F1 · balance_after: Includes 14,510 shares which were granted as restricted stock pursuant to the Company's Amended and Restated 2003 Stock Incentive Plan. Restrictions lapse as to 1,714 shares on November 20, 2025, 1,726 shares on March 6, 2026, 1,246 shares on each of May 20, 2026, August 20, 2026, and November 20, 2026, 1,252 shares on March 6, 2027, 1,012 shares on each of May 20, 2027, August 20, 2027, and November 20, 2027, 1,016 shares on March 6, 2028, 506 shares of each on May 20, 2028, August 20, 2028, and November 20, 2028, and 510 shares on March 6, 2029, if he is an employee of the Company on those dates. Read SEC document |
| August 21, 2025 Filed Aug 21, 2025 23:54 UTC | SaleCommon Stock | 763 | $84.97 | $64,832.11 |
DisclosureSEC source: 0000950170-25-110761 · ownership.xml · nonDerivative · entry 1 REEVE GRAHAM D. · CIK 0001519948 · COO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 21,483 F1 · price: The price reported $84.97 is the weighted average price. The shares were sold in multiple transactions at prices ranging from $84.90 to $85.02 per share, both inclusive. The reporting person undertakes to provide to U.S. Physical Therapy, Inc., any of its shareholders or the staff of the Securities & Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4. F2 · balance_after: Includes 15,296 shares which were granted as restricted stock pursuant to the Company's Amended and Restated 2003 Stock Incentive Plan. Restrictions lapse as to 1,948 shares on November 20, 2025. 1,964 shares on March 6, 2026, 1,324 shares on each of May 20, 2026, August 20, 2026, and November 20, 2026, 1,332 shares on March 6, 2027, 1,012 shares on each of May 20, 2027, August 20, 2027, and November 20, 2027, 1,016 shares on March 6, 2028, 506 shares of each on May 20, 2028, August 20, 2028, and November 20, 2028, and 510 shares on March 6, 2029, if he is an employee of the Company on those dates. Read SEC document |
|
| August 19, 2025 Filed Aug 19, 2025 21:30 UTC |
Binstein RichardEVP Gen'l Counsel & Secretary
|
Disposition to issuerCommon Stock | 2,000 | $84.79 | $169,580.00 |
DisclosureSEC source: 0000950170-25-110193 · ownership.xml · nonDerivative · entry 1 Binstein Richard · CIK 0001919840 · EVP Gen'l Counsel & Secretary 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,867 F1 · balance_after: Includes 15,726 shares which were granted as restricted stock pursuant to the Company's Amended and Restated 2003 Stock Incentive Plan. Restrictions lapse as to 1,551 shares on each of August 20, 2025, and November 20, 2025, 1,554 shares on March 6, 2026, 1,246 shares on each of May 20, 2026, August 20, 2026, and November 20, 2026,1,252 shares on March 6, 2027, 1,012 shares on each of May 20, 2027, August 20, 2027, and November 20, 2027, 1,016 shares on March 6, 2028, 506 shares of each on May 20, 2028, August 20, 2028, and November 20, 2028, and 510 shares on March 6, 2029, if he is an employee of the Company on those dates. Read SEC document |
| August 11, 2025 Filed Aug 13, 2025 01:00 UTC | SaleCommon Stock | 1,792 | $86.57 | $155,133.44 |
DisclosureSEC source: 0000950170-25-107551 · ownership.xml · nonDerivative · entry 1 REEVE GRAHAM D. · CIK 0001519948 · COO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 22,246 F1 · balance_after: Includes 17,244 shares which were granted as restricted stock pursuant to the Company's Amended and Restated 2003 Stock Incentive Plan. Restrictions lapse as to 1,948 shares on each of August 20, 2025, and November 20, 2025, 1,964 shares on March 6, 2026, 1,324 shares on each of May 20, 2026, August 20, 2026, and November 20, 2026, 1,332 shares on March 6, 2027, 1,012 shares on each of May 20, 2027, August 20, 2027, and November 20, 2027, 1,016 shares on March 6, 2028, 506 shares of each on May 20, 2028, August 20, 2028, and November 20, 2028, and 510 shares on March 6, 2029, if he is an employee of the Company on those dates. Read SEC document |
|
| June 12, 2025 Filed Jun 13, 2025 20:30 UTC |
HAM NANCYDirector
|
SaleCommon Stock | 400 | $78.01 | $31,204.00 |
DisclosureSEC source: 0000950170-25-086255 · ownership.xml · nonDerivative · entry 1 HAM NANCY · CIK 0001124500 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,594 F1 · price: The price reported is weighted average price ($78.01). The shares were sold in multiple transactions at prices ranging from $77.99 to $78.03 per share, both inclusive. The reporting person undertakes to provide to U.S. Physical Therapy, Inc., any of its shareholders or the staff of the Securities & Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4. F2 · balance_after: Includes 1,882 shares which were granted as restricted stock pursuant to the Company Amended and Restated 2003 Stock Incentive Plan. Restrictions lapse as to 941 shares on August 20, 2025, 470 shares on November 20, 2025, and 471 shares on March 6, 2026, if she is a director of the Company on those dates. Read SEC document |
| May 21, 2025 Filed May 22, 2025 20:30 UTC | SaleCommon Stock | 530 | $78.08 | $41,382.40 |
DisclosureSEC source: 0000950170-25-076382 · ownership.xml · nonDerivative · entry 1 REEVE GRAHAM D. · CIK 0001519948 · COO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,244 F1 · price: The price reported is the weighted average price ($78.08) . The shares were sold in multiple transactions at prices ranging from $77.83 to $78.35 per share, both inclusive. The reporting person undertakes to provide to U.S. Physical Therapy, Inc., any of its shareholders or the staff of the Securities & Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4. F2 · balance_after: Includes 17,244 shares which were granted as restricted stock pursuant to the Company's Amended and Restated 2003 Stock Incentive Plan. Restrictions lapse as to 1,948 shares on each of August 20, 2025, and November 20, 2025, 1,964 shares on March 6, 2026, 1,324 shares on each of May 20, 2026, August 20, 2026, and November 20, 2026, 1,332 shares on March 6, 2027, 1,012 shares on each of May 20, 2027, August 20, 2027, and November 20, 2027, 1,016 shares on March 6, 2028, 506 shares of each on May 20, 2028, August 20, 2028, and November 20, 2028, and 510 shares on March 6, 2029, if he is an employee of the Company on those dates. Read SEC document |
|
| May 21, 2025 Filed May 22, 2025 20:30 UTC |
Williams Eric JosephPresident and COO
|
SaleCommon Stock | 633 | $78.09 | $49,430.97 |
DisclosureSEC source: 0000950170-25-076378 · ownership.xml · nonDerivative · entry 1 Williams Eric Joseph · CIK 0001871391 · President and COO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 26,331 F1 · price: The price reported $78.09 is the weighted average price. The shares were sold in multiple transactions at prices ranging from $77.83 to $78.35 per share, both inclusive. The reporting person undertakes to provide to U.S. Physical Therapy, Inc., any of its shareholders or the staff of the Securities & Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4. F2 · balance_after: Includes 20,382 shares which were granted as restricted stock pursuant to the Company's Amended and Restated 2003 Stock Incentive Plan. Restrictions lapse as to 2,172 shares on each of August 20, 2025, 1,888 shares on November 20, 2025, 1,896 shares on March 6, 2026, 1,576 shares on each of May 20, 2026, August 20, 2026, and November 20, 2026, 1,584 shares on March 6, 2027, 1,264 shares on each of May 20, 2027, August 20, 2027, and November 20, 2027, 1,268 shares on March 6, 2028, 758 shares of each on May 20, 2028, August 20, 2028, November 20, 2028, and 780 shares on March 6, 2029, if he is an employee of the Company on those dates. Read SEC document |
| May 20, 2025 Filed May 21, 2025 20:15 UTC |
Harris Bernard A JrDirector
|
GrantCommon Stock | 1,882 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-075788 · ownership.xml · nonDerivative · entry 1 Harris Bernard A Jr · CIK 0001337906 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,608 F1 · shares: Includes 1,882 shares which were granted as restricted stock pursuant to the Company Amended and Restated 2003 Stock Incentive Plan. Restrictions lapse as to 941 shares on August 20, 2025, 470 shares on November 20, 2025, and 471 shares on March 6, 2026, if he is a director of the Company on those dates. F1 · balance_after: Includes 1,882 shares which were granted as restricted stock pursuant to the Company Amended and Restated 2003 Stock Incentive Plan. Restrictions lapse as to 941 shares on August 20, 2025, 470 shares on November 20, 2025, and 471 shares on March 6, 2026, if he is a director of the Company on those dates. Read SEC document |
| May 20, 2025 Filed May 21, 2025 20:15 UTC |
Trier ClaytonDirector
|
GrantCommon Stock | 1,882 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-075784 · ownership.xml · nonDerivative · entry 1 Trier Clayton · CIK 0001319561 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,306 F1 · shares: Includes 1,882 shares which were granted as restricted stock pursuant to the Company Amended and Restated 2003 Stock Incentive Plan. Restrictions lapse as to 941 shares on August 20, 2025, 470 shares on November 20, 2025, and 471 shares on March 6, 2026, if he is a director of the Company on those dates. F1 · balance_after: Includes 1,882 shares which were granted as restricted stock pursuant to the Company Amended and Restated 2003 Stock Incentive Plan. Restrictions lapse as to 941 shares on August 20, 2025, 470 shares on November 20, 2025, and 471 shares on March 6, 2026, if he is a director of the Company on those dates. Read SEC document |
| May 20, 2025 Filed May 21, 2025 20:15 UTC |
Swanson Regg E.Director
|
GrantCommon Stock | 1,882 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-075786 · ownership.xml · nonDerivative · entry 1 Swanson Regg E. · CIK 0001412473 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,186 F1 · shares: Includes 1,882 shares which were granted as restricted stock pursuant to the Company Amended and Restated 2003 Stock Incentive Plan. Restrictions lapse as to 941 shares on August 20, 2025, 470 shares on November 20, 2025, and 471 shares on March 6, 2026, if he is a director of the Company on those dates. F1 · balance_after: Includes 1,882 shares which were granted as restricted stock pursuant to the Company Amended and Restated 2003 Stock Incentive Plan. Restrictions lapse as to 941 shares on August 20, 2025, 470 shares on November 20, 2025, and 471 shares on March 6, 2026, if he is a director of the Company on those dates. Read SEC document |
| May 20, 2025 Filed May 21, 2025 20:15 UTC |
HAM NANCYDirector
|
GrantCommon Stock | 1,882 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-075782 · ownership.xml · nonDerivative · entry 1 HAM NANCY · CIK 0001124500 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,994 F1 · shares: Includes 1,882 shares which were granted as restricted stock pursuant to the Company Amended and Restated 2003 Stock Incentive Plan. Restrictions lapse as to 941 shares on August 20, 2025, 470 shares on November 20, 2025, and 471 shares on March 6, 2026, if she is a director of the Company on those dates. F1 · balance_after: Includes 1,882 shares which were granted as restricted stock pursuant to the Company Amended and Restated 2003 Stock Incentive Plan. Restrictions lapse as to 941 shares on August 20, 2025, 470 shares on November 20, 2025, and 471 shares on March 6, 2026, if she is a director of the Company on those dates. Read SEC document |
| May 20, 2025 Filed May 21, 2025 20:15 UTC |
Motsenbocker AnneDirector
|
GrantCommon Stock | 1,882 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-075781 · ownership.xml · nonDerivative · entry 1 Motsenbocker Anne · CIK 0001904253 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,506 F1 · shares: Includes 1,882 shares which were granted as restricted stock pursuant to the Company Amended and Restated 2003 Stock Incentive Plan. Restrictions lapse as to 941 shares on August 20, 2025, 470 shares on November 20, 2025, and 471 shares on March 6, 2026, if she is a director of the Company on those dates. F1 · balance_after: Includes 1,882 shares which were granted as restricted stock pursuant to the Company Amended and Restated 2003 Stock Incentive Plan. Restrictions lapse as to 941 shares on August 20, 2025, 470 shares on November 20, 2025, and 471 shares on March 6, 2026, if she is a director of the Company on those dates. Read SEC document |
| May 20, 2025 Filed May 21, 2025 20:15 UTC |
Gilmartin Kathleen ADirector
|
GrantCommon Stock | 1,882 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-075778 · ownership.xml · nonDerivative · entry 1 Gilmartin Kathleen A · CIK 0001741732 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,786 F1 · shares: Includes 1,882 shares which were granted as restricted stock pursuant to the Company Amended and Restated 2003 Stock Incentive Plan. Restrictions lapse as to 941 shares on August 20, 2025, 470 shares on November 20, 2025, and 471 shares on March 6, 2026, if she is a director of the Company on those dates. F1 · balance_after: Includes 1,882 shares which were granted as restricted stock pursuant to the Company Amended and Restated 2003 Stock Incentive Plan. Restrictions lapse as to 941 shares on August 20, 2025, 470 shares on November 20, 2025, and 471 shares on March 6, 2026, if she is a director of the Company on those dates. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.